Alentis Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series D

Recent Raise

$181.4M

Alentis Therapeutics is a biotech company developing antibody-drug conjugates for treating Claudin-1 positive tumors and organ fibrosis.